Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Employment agrmnt
Appointed director
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 144 Form 144 - Report of proposed sale of securities:
07/27/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/31/2023 SD Form SD - Specialized disclosure report:
05/23/2023 8-K Material Impairments, Regulation FD Disclosure  Interactive Data
05/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/26/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/26/2023 8-K Quarterly results
04/06/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/24/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "45810CAT5 SEVENTH AMENDED AND RESTATED CREDIT AGREEMENT",
"10.2 RATIFICATION AGREEMENT RATIFICATION AGREEMENT"
02/22/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
02/22/2023 10-K Annual Report for the period ended December 31, 2022
02/22/2023 8-K Quarterly results
02/14/2023 SC 13G/A Tru St Partnership, L.P. reports a 10.2% stake in Integra LifeSciences Holdings Corporation
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.6% stake in Integra LifeSciences Holdings Corp.
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/31/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/26/2023 8-K Entered into an accelerated share repurchase agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549"
01/25/2023 8-K Results of Operations and Financial Condition  Interactive Data
01/25/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/10/2023 8-K Investor presentation
Docs: "Exhibit 99.1 Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials Fourth Quarter 2022",
"2023 JP Morgan Healthcare Conference January 11, 2023 Exhibit 99.2 Safe Harbor Disclosure 2 Safe Harbor This"
12/14/2022 8-K Quarterly results
12/01/2022 8-K Quarterly results
10/26/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/26/2022 8-K Quarterly results
10/11/2022 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 6.4% stake in INTEGRA LIFESCIENCES HOLDINGS CORPORATION
09/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SEPARATION AGREEMENT AND GENERAL RELEASE"
08/29/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/24/2022 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549"
07/27/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
07/27/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/27/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy